Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
101 J Morris Commons Lane, Morrisville, NC, 27560, US
FUJIFILM Irvine Scientific becomes FUJIFILM Biosciences and FUJIFILM Diosynth Biotechnologies will be known as FUJIFILM Biotechnologies.
Fujifilm to provide U.S.-based manufacturing for Regeneron at its new large-scale biopharmaceutical manufacturing facility in Holly Springs, NC.
By: Rachel Klemovitch
Upgrades its development labs and adds two new independent cell therapy production suites, significantly increasing cleanroom capacity for new client programs.
By: Charlie Sternberg
First phase adds six mammalian cell bioreactors, bringing the total capacity at the Hillerød site to 12 x 20,000 L bioreactors.
Signs a manufacturing supply agreement with TG Therapeutics for BRIUMVI.
Aims to further expand the planned FUJIFILM Diosynth Biotechnologies end-to-end bio-manufacturing facility.
Samsung Biologics, Fujifilm Diosynth Biotechnologies, WuXi STA and more shared major news—including investments, expansions & acquisitions.
McAvoy will be responsible for financial strategies, financial activities, and financial management contributing to the company’s growth strategy.
By: Kristin Brooks
Pedersen has 20 years of leadership experience in the life sciences and biopharma space.
By: Anthony Vecchione
New unit to provide tailored support to large-and small-scale biopharmaceutical customers.
To focus on research and facility design to support Fujifilm’s goal to achieve net-zero carbon emissions by 2030 for its new $2 billion site in Holly Springs.
By: Tim Wright
The expansion will add a new cGMP production facility that will be operational by 2024.
Large-scale facility will include more than 20,000 sq. ft. of modular clean room space and will increase microbial production by 70%.
Will enhance Fujifilm Diosynth Biotechnologies’ sites in Hillerød, Denmark, and Texas in the U.S.
Expansion will double the site’s existing lab footprint with an addition of 89,000 sq. ft equipped with state-of-the-art instrumentation and technologies.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
